Portage Biotech
PRTG
#8194
Rank
$9.47 M
Marketcap
British Virgin Islands
Country
$0.48
Share price
91.56%
Change (1 day)
-86.92%
Change (1 year)
Categories
Earnings for Portage Biotech (PRTG)
Earnings in 2023 (TTM): -$0.17 B
According to Portage Biotech's latest financial reports the company's current earnings (TTM) are -$0.17 B. a decrease over its 2022 earnings that were of -$17.07 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Portage Biotech from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023  | -$0.17 B | 892.45% |
| 2022 | -$17.07 M | -18.44% |
| 2021 | -$20.93 M | 348.58% |
| 2020 | -$4.67 M | -39.96% |
| 2019 | -$7.77 M | -106.26% |
| 2018 | $0.12 B | -621.51% |
| 2017 | -$23.81 M | -213.76% |
| 2016 | $20.92 M | -336.72% |
| 2015 | -$8.85 M | 81.72% |
| 2014 | -$4.87 M | -4.91% |
| 2013 | -$5.12 M | |
| 2007 | -$0.02 M | -101.23% |
| 2006 | $0.91 M | -116.89% |
| 2005 | -$5.44 M | 264.28% |
| 2004 | -$1.5 M | 650.8% |
| 2003 | -$0.2 M | -54.15% |
| 2002 | -$0.44 M | 11.37% |
| 2001 | -$0.39 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -$2.17 M | -98.72% | Bahamas |
 NRC Health
NRC | $40.37 M | -123.84% | 🇺🇸 USA |